saturation levels in a significant manner³.
Technology Innovation Leadership award
Latest news and press releases
Inspira™ Technologies Reports Third Quarter 2022 Financial Results
Inspira™ Technologies Signs a Strategic Agreement in Europe to potentially provide $26.1 Million for Deployment of 1,364 HYLA™ Blood Sensors
These reports are prepared by independent analysts. Inspira does not endorse or distribute such reports and takes no responsibility for the accuracy or completeness of the material contained in the reports. Please note that any opinions, estimates or forecasts regarding the company’s performance made by these analysts are theirs alone and do not represent opinions, forecasts, or predictions of Inspira Technologies.